199 related articles for article (PubMed ID: 31886191)
1. A Meta-Analysis on the Seroprevalence of Parvovirus B19 among Patients with Sickle Cell Disease.
Obeid Mohamed SO; Osman Mohamed EM; Ahmed Osman AA; Abdellatif MohamedElmugadam FA; Abdalla Ibrahim GA
Biomed Res Int; 2019; 2019():2757450. PubMed ID: 31886191
[TBL] [Abstract][Full Text] [Related]
2. Parvovirus B19 infection in sickle cell disease: An analysis from the Centers for Disease Control haemoglobinopathy blood surveillance project.
Majumdar S; Bean CJ; De Staercke C; Bost J; Nickel R; Coates T; Campbell A; Thompson A
Transfus Med; 2020 Jun; 30(3):226-230. PubMed ID: 32131139
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence and geographical distribution of parvovirus B19 antibodies in pregnant women: A-meta analysis.
Moosazadeh M; Alimohammadi M; Mousavi T
J Immunoassay Immunochem; 2023 Mar; 44(2):103-116. PubMed ID: 36661768
[TBL] [Abstract][Full Text] [Related]
4. Parvovirus B19 infection and kidney injury: report of 4 cases and analysis of immunization and viremia in an adult cohort of 100 patients undergoing a kidney biopsy.
Kauffmann M; Bobot M; Daniel L; Torrents J; Knefati Y; Moranne O; Burtey S; Zandotti C; Jourde-Chiche N
BMC Nephrol; 2020 Jul; 21(1):260. PubMed ID: 32646497
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of human parvovirus B19 in children with sickle cell disease.
Smith-Whitley K; Zhao H; Hodinka RL; Kwiatkowski J; Cecil R; Cecil T; Cnaan A; Ohene-Frempong K
Blood; 2004 Jan; 103(2):422-7. PubMed ID: 14525777
[TBL] [Abstract][Full Text] [Related]
6. A literature review on the parvovirus B19 infection in sickle cell anemia and β-thalassemia patients.
Soltani S; Zakeri A; Tabibzadeh A; Zandi M; Ershadi E; Akhavan Rezayat S; Khaseb S; Zakeri AM; Ashtar Nakhaei M; Afzali S; Farahani A
Trop Med Health; 2020 Dec; 48(1):96. PubMed ID: 33292852
[TBL] [Abstract][Full Text] [Related]
7. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
[TBL] [Abstract][Full Text] [Related]
8. Saccharomyces cerevisiae-derived virus-like particle parvovirus B19 vaccine elicits binding and neutralizing antibodies in a mouse model for sickle cell disease.
Penkert RR; Young NS; Surman SL; Sealy RE; Rosch J; Dormitzer PR; Settembre EC; Chandramouli S; Wong S; Hankins JS; Hurwitz JL
Vaccine; 2017 Jun; 35(29):3615-3620. PubMed ID: 28554503
[TBL] [Abstract][Full Text] [Related]
9. [Seroprevalence of human parvovirus B19 in children with fever and rash in the North of Tunisia].
Bouafsoun A; Hannachi N; Smaoui H; Boubaker SH; Kazdaghli K; Laabidi D; Boukadida J; Kechrid A
Bull Soc Pathol Exot; 2016 Aug; 109(3):165-71. PubMed ID: 27385036
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
Chehadeh W; Halim MA; Al-Nakib W
Virology; 2009 Jul; 390(1):56-63. PubMed ID: 19450862
[TBL] [Abstract][Full Text] [Related]
11. Transient aplastic crisis in patients with sickle cell disease. B19 parvovirus studies during a 7-year period.
Rao SP; Miller ST; Cohen BJ
Am J Dis Child; 1992 Nov; 146(11):1328-30. PubMed ID: 1415073
[TBL] [Abstract][Full Text] [Related]
12. Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy.
Dobec M; Juchler A; Flaviano A; Kaeppeli F
Gynecol Obstet Invest; 2007; 63(1):53-4. PubMed ID: 16940737
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of human parvovirus B19 amongst North Indian blood donors - do current donor testing guidelines need a relook?
Raturi G; Kaur P; Kaur G
Transfus Apher Sci; 2018 Oct; 57(5):646-650. PubMed ID: 30087085
[TBL] [Abstract][Full Text] [Related]
14. Parvovirus B19 Seroprevalence in Women with Bad Obstetric History in Kirkuk.
Alsamarai AM; Hassan HM; Alsamarai MA; Aljumaili ZK
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(4):359-366. PubMed ID: 34315400
[TBL] [Abstract][Full Text] [Related]
15. [Parvovirus B19 infection: the general aspects and gestational problems].
Di Stefano L; Carta G; Barnabei R; Tomei E; Toro G; Moscarini M
Minerva Ginecol; 1995 Apr; 47(4):121-5. PubMed ID: 7644092
[TBL] [Abstract][Full Text] [Related]
16. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus.
Chernak E; Dubin G; Henry D; Naides SJ; Hodinka RL; MacGregor RR; Friedman HM
Clin Infect Dis; 1995 Jan; 20(1):170-3. PubMed ID: 7727646
[TBL] [Abstract][Full Text] [Related]
17. Kawasaki disease associated with parvovirus B19 infection.
Holm JM; Hansen LK; Oxhøj H
Eur J Pediatr; 1995 Aug; 154(8):633-4. PubMed ID: 7588963
[TBL] [Abstract][Full Text] [Related]
18. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection.
Kerr JR; Coyle PV; DeLeys RJ; Patterson CC
J Med Virol; 1996 Jan; 48(1):68-75. PubMed ID: 8825713
[TBL] [Abstract][Full Text] [Related]
19. Human B19 parvovirus infection in an obstetric population. A prospective study determining fetal outcome.
Guidozzi F; Ballot D; Rothberg AD
J Reprod Med; 1994 Jan; 39(1):36-8. PubMed ID: 8169914
[TBL] [Abstract][Full Text] [Related]
20. The seroprevalence of parvovirus B19 antibody in blood donors at the National Blood Transfusion Center in Kinshasa.
Chabo Byaene A; Kabututu ZP; Abou Rayia DM; El-Sokkary MMA
J Med Virol; 2020 Mar; 92(3):288-294. PubMed ID: 31646654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
